Cold Chain Products Market in terms of revenue was estimated to be worth $569 million in 2022 and is poised to reach $711 million by 2027, growing at a CAGR of 4.5% from 2022 to 2027 according to a new report by MarketsandMarkets™. Factors such as the rising zoonotic disease concerns, Rising use of immunoglobulins and other plasma products in a range of therapeutic areas and Increasing demand for Plasma-derived medicinal products driving the growth of the Cold Chain Products Market for Plasma Fractionation. However, shortage of trained manpower & limited resources to maintain the equipment and Environmental concerns regarding greenhouse gas emissions will be challenges in the growth of this market during the forecast period.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159802939
Browse in-depth TOC on “Cold Chain Products Market”
120 – Tables
50 – Figures
200 – Pages
In this report, the Cold Chain Products Market for Plasma Fractionation is segmented based on type, end user, and region.
“Temperature monitoring devices segment is expected to witness the fastest growth in the forecast period.”
The Cold Chain Products for Plasma Fractionation market is categorized into seven types, including Ultra-low temperature freezers, Plasma freezers, Temperature monitoring devices, Plasma contact shock freezers, Blood transport boxes, Ice-lined refrigerators, and Others. Among these categories, the Temperature monitoring devices segment is projected to experience the highest growth rate from 2022 to 2027. Increased research and development investment in medical devices such as medical freezers and refrigerators are additional factors that are anticipated to drive market growth during the forecasted period
“Blood collection centers and blood component providers accounted for the largest share of the Cold Chain Products Market for Plasma Fractionation in 2021.”
The Cold Chain Products Market for Plasma Fractionation is categorized into different end users, including Blood collection centers and blood component providers, Hospitals and transfusion centers, Clinical research laboratories, and Others. Among these, the Blood collection centers, and blood component providers segment held the fastest-growing market for cold chain products for plasma fractionation in 2021. This significant market share can be attributed to factors such as the increasing prevalence of diseases like hemophilia, immune deficiency disorders, and liver diseases, as well as the growing aging population.
“North America accounted for the largest share of the Cold Chain Products Market for Plasma Fractionation in 2021”
The Cold Chain Products Market for Plasma Fractionation is segmented into five geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America emerged as the dominant market for Cold Chain Products for Plasma Fractionation worldwide. The increasing demand for plasma freezers and the availability of advanced cold storage devices for laboratories are expected to be major driving factors for market growth in North America. The region’s substantial market share can be attributed to its well-developed healthcare infrastructure and the continuous investment in research and development of medical devices such as medical freezers and refrigerators.
Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=159802939
Cold Chain Products Market Dynamics:
Drivers:
- Growing adoption of hybrid operating rooms
Restraints:
- Increasing adoption of refurbished medical displays
Opportunities:
- Increasing investments from government bodies and private players in healthcare sectors in emerging economies
Challenges:
- Adoption of consumer-grade displays
Key Market Players:
The prominent players in the global Cold Chain Products Market for Plasma Fractionation are B Medical Systems (US), Blue Star Limited (India), Thermo Fisher Scientific (US), Godrej and Boyce Manufacturing Co. Ltd. (India), Haier Biomedical (China), Eppendorf SE (Germany), Avantor, Inc. (US), Biolife Solutions Inc. (US), and Helmer Scientific Inc. (US).
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=159802939
Recent Developments:
- In April 2023, LG electronics launched 32HQ713D-B, which has latest high-resolution 8MP diagnostic medical monitor. It combines 1000 nits of brightness with LG’s proprietary IPS Black panel to deliver an enhanced 2,000:1 contrast ratio with deep blacks, while greatly simplifying color calibration through an automatic integrated sensor and software.
- In February 2023, Eizo launched a 21.3-inch 2-megapixel (1200 x 1600 pixels) color monitor for displaying patient charts and reviewing diagnostic imaging in hospital and clinic environments.
- In November 2022, Barco launched two displays. Io Gray 5.8 MP for the breast imaging and MDSC-8532 and MDSC-8527 4K UHD for surgical display.
- In July 2022, Eizo launched launched four new monitors ranging from 32 to 55 inches with 4K UHD resolution (3840 x 2160 pixels) for use in endoscopy, microsurgery, and other high-precision procedures in the operating room (OR).
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/cold-chain-product-market-159802939.html